MTOR and hepatocellular carcinoma: In HCC cell lines responsive to the mTOR inhibitor rapamycin, as the concentration of rapamycin increased, DNMT1 expression was decreased and cell proliferation was inhibited at the same time (Additional file 1: Fig. S5A, B).